TSX
Every company in the roster listed on TSX.
Every company in the roster listed on TSX.
3 of 3 companies
| Company | Pipeline | Most advanced | Next readout | Market cap | Cash & inv. | Runway | R&D / yr |
|---|---|---|---|---|---|---|---|
HLS Therapeutics Inc.HLS · TSX | 2 assets: 2 approved | Approved assets only | None on record | — | — | — | — |
Knight TherapeuticsGUD · TSX | 6 assets: 6 approved | Approved assets only | Dec 2026viloxazine · Phase 3 | — | — | — | — |
Medicenna Therapeutics, Inc.MDNA · TSX | 2 assets: 2 Ph 2 | bizaxofuspPhase 2 · Recurrent Glioblastoma | 20 Oct 2028MDNA11 · Phase 1/2 | — | — | — | — |
Next readout: the earliest estimated primary completion of a trial the company or a partner on the asset runs (ClinicalTrials.gov). Cash shows its balance-sheet month; runway shows a month only when it comes from an earlier report.